尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Borkowski Astrid. Director active across 1 company, notably HilleVax, Inc.. In total, 7 disclosures have been logged. Breakdown: 0 buy · 5 sells. Total volume traded: €516k. Activity tracked since 1 February 2023. The latest transaction was filed on 8 February 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Borkowski Astrid is a declarant linked to HilleVax, Inc., where she holds the role of Chief Medical Officer. She has 7 filings in total, and the 7 sampled filings, between 2023-02-03 and 2024-02-12, show only sales for a total of EUR 662169.